We are testing the drug abatacept to see if it can delay or prevent progression of early stage T1D (stage 1) from progression to stage 2, and ultimately prevent clinical diagnosis (stage 3).
Study Details
Abatacept effects the autoimmune response that can result in the progression of type 1 diabetes.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec vulputate ligula eget finibus pretium. Etiam fringilla, sapien id porta egestas, turpis velit malesuada purus, nec tincidunt justo arcu et ligula. Proin tincidunt, libero id scelerisque pharetra, tellus sem dapibus tortor, sed venenatis ligula ligula at purus. Nulla facilisi. Duis mattis diam convallis, faucibus elit at, malesuada arcu.
- Sample unordered list shown here.
- Sample unordered list shown here.
- Sample unordered list shown here.
Sed et velit leo. Vivamus metus arcu, consectetur eu libero at, fermentum pellentesque dolor. Proin porta lectus purus, eget dictum augue sollicitudin a. Vestibulum ligula dui, sollicitudin iaculis placerat in, vulputate ut metus. Pellentesque condimentum semper sem, eu venenatis leo scelerisque in.
Ut blandit risus non velit porttitor, at congue ligula dictum. Donec vitae mollis velit. Duis eu turpis ligula. Morbi iaculis eu neque at rhoncus. Ut consequat leo ac arcu placerat efficitur.
Regardless of which group you are in, you play an important role in advancing T1D research for the immediate study and well into the future.
Donec in odio posuere, consectetur nibh quis, ullamcorper ipsum. Morbi sem magna, ullamcorper ut metus at, vulputate sagittis nisl. Fusce hendrerit venenatis nisi, sed ultrices sapien rhoncus non. Pellentesque magna elit, viverra sit amet diam eget, blandit vehicula velit.
Vestibulum mattis eu lacus non suscipit. Nullam lacinia sem dui, non vulputate augue consequat quis. Maecenas id eros sit amet sem condimentum finibus vel sit amet erat. Duis mollis dignissim turpis a venenatis. Maecenas congue cursus hendrerit. Nullam vel euismod libero.
In addition to the studies listed here, TrialNet is always planning future clinical research. If we don’t currently offer a study that’s right for you, you can opt into monitoring by a TrialNet research team. When the first study opens, you’ll be the first to know!
